Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators. 
Reis SE, Costantino JP, Wickerham DL, Tan-Chiu E, Wang J, Kavanah M. Journal of the National Cancer Institute. 2001;93:16-21.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [see comments]. [Review].
Gail MH, Costantino JP, Bryant J, et al. Journal of the National Cancer Institute. 1999;91:1829-46.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma [see comments]. 
Fisher ER, Dignam J, Tan-Chiu E, et al. Cancer. 1999;86:429-38.

Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. 
Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Journal of Clinical Oncology. 1999;17:2659-69.

Validation studies for models projecting the risk of invasive and total breast cancer incidence. 
Costantino JP, Gail MH, Pee D, et al. Journal of the National Cancer Institute. 1999;91:1541-8.

Long-term tamoxifen citrate use and potential ocular toxicity [published erratum appears in Am J Ophthalmol 1998 Aug;126(2):338]. 
Gorin MB, Day R, Costantino JP, et al. American Journal of Ophthalmology. 1998;125:493-501.

Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial. 
Ganz PA, Day R, Costantino J. Statistics in Medicine. 1998;17:613-22.

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. 
Fisher B, Dignam J, Wolmark N, et al. Journal of Clinical Oncology. 1998;16:441-52.

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study [see comments]. 
Fisher B, Costantino JP, Wickerham DL, et al. Journal of the National Cancer Institute. 1998;90:1371-88.

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer. 
Bryant J, Fisher B, Gunduz N, Costantino JP, Emir B. Breast Cancer Research & Treatment. 1998;51:239-53.

Average Annual Rates of Invasive and Noninvasive Breast Cancer by History of LCIS and Atypical Hyperplasia for Participants in the BCPT (Meeting abstract). 
Wickerham Donald, Costantino Josep, Fisher Bernar, Kavanah Mauree, Wolmark Norma. Proc Annu Meet Am Soc Clin Oncol. 18:A327, 1999.

National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (BCPT) Summary Analysis of Transvaginal Sonography and Endometrial Biopsy in Detecting Endometrial Pathology. (Meeting abstract). 
Runowicz Carolyn, Costantino J, Kavanah MT, et al. Proc Annu Meet Am Soc Clin Oncol. 18:A1380, 1999.

Health-Related Quality of Life (HRQL) and Tamoxifen in Breast Cancer Prevention (Meeting abstract). 
Day R, Ganz P, Costantino J, Wickerham D, Cronin W. Proc Annu Meet Am Soc Clin Oncol. 18:A2284, 1999.

Effect of Tamoxifen on Cardiac Risk Factors in Women Without Cancer: The Breast Cancer Prevention Trial (Meeting abstract).
Cushman Mar, Costantino Joseph, Bovill Edwin, et al. Proc Annu Meet Am Soc Clin Oncol. 18:A283, 1999.